Paola Francica
Bern, BE 3008, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
LRRC8A as a candidate biomarker of cisplatin sensitivity in muscle-invasive bladder cancer: an exploratory immunohistochemical study.
Journal: International urology and nephrology
Published: June 26, 2026
Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.
Journal: NPJ precision oncology
Published: February 13, 2026
Docetaxel response in BRCA1,p53-deficient mammary tumor cells is affected by Huntingtin and BAP1.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 20, 2024
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours.
Journal: Nature communications
Published: March 20, 2024
DNA Damage Response and Mismatch Repair Gene Defects in Advanced and Metastatic Prostate Cancer.
Journal: Advances in anatomic pathology
Published: November 27, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells.
Journal: Cell reports
Published: September 02, 2022
Meiotic Genes and DNA Double Strand Break Repair in Cancer.
Journal: Frontiers in genetics
Published: December 08, 2021
Functional Radiogenetic Profiling Implicates ERCC6L2 in Non-homologous End Joining.
Journal: Cell reports
Published: December 18, 2019
Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response.
Journal: Genome medicine
Published: December 30, 2018
Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Journal: Molecular cancer therapeutics
Published: November 13, 2018
Last Updated: 09/26/2026